Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Supercharged immune cells take on advanced melanoma in new trial
Disease control CompletedThis phase 2 trial tested a personalized cell therapy called lifileucel for people with advanced melanoma that had spread and stopped responding to standard treatments. Researchers took immune cells from each patient's tumor, multiplied them in a lab, and infused them back after …
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Experimental cell therapy takes on Hard-to-Treat blood cancers
Disease control CompletedThis early-phase trial tested a new cell therapy called IOV-2001 in 7 patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that had stopped responding to standard drugs. The therapy uses a patient's own immune cells, which are collected, processed,…
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC